Contact dermatitis (CD) is a type of eczema triggered by contact with a particular substance in the environment that the person is allergic to, it may react by causing the skin to itch and become red. CD usually improves or clears up completely if the substance causing the problem is identified and avoided. Treatments are also available to help ease the symptoms. Clinical symptoms depend primarily on whether the dermatitis is acute or chronic, as well as on the toxin involved, type of contact, pathomechanism, and localization, among other factors. Although all types of dermatitis generally share common features, the classic eczematous stages in CD are most readily Identifiable.
DelveInsight's "Contact Dermatitis Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Contact Dermatitis market size and shares analysis in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The report also covers emerging drugs, current treatment practices, Contact Dermatitis market shares of the individual therapies, a detailed current Contact Dermatitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the market.
Contact Dermatitis Epidemiology Forecast
There are two most common types of CD, namely, Irritant Contact Dermatitis (ICD) and Allergic contact dermatitis (ACD). ICD is more common (80%) and can occur in anyone, especially after repeated exposure. ACD, on the other hand, is seen in genetically predisposed and previously sensitized individuals who react to even low concentrations of the agent. Cosmetics, medicines, clothes dyes, as well as foods, rubber, and poison ivy, are common causes of ACD. ICD is caused by skin injury, direct cytotoxic effects, or cutaneous inflammation from contact with an irritant. On the other hand, ACD is caused by a type IV, T cell-mediated, delayed hypersensitivity reaction in which a foreign substance comes into contact with the skin and is linked to skin protein, forming an antigen complex that leads to sensitization.
Contact Dermatitis Epidemiology Segmentation-
- Total Diagnosed Prevalent Population of Contact Dermatitis
- Age-specific Diagnosed Prevalent Population of Contact Dermatitis
- Type-specific Diagnosed Prevalent Population of Contact Dermatitis
- Gender-specific Diagnosed Prevalent Population of Contact Dermatitis
- Type-specific Diagnosed Prevalent Population of CD Based on Clinical and Biological Evolution
The Contact Dermatitis epidemiology section covers insights about historical and current Contact Dermatitis patient pool and forecasted trends for every seven major countries (i.e., the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
It helps to recognize the causes of current and forecasted Contact Dermatitis Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Contact Dermatitis Market Share
The Contact Dermatitis market size is expected to increase during the forecast period owing to the rise in the number of prevalent cases in the 7MM.
The Contact Dermatitis market analysis section of the report helps to understand the current and forecasted Contact Dermatitis market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers. The report gives complete detail of Contact Dermatitis market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Contact Dermatitis Market Drivers
- Futuristic Market Opportunity for Key Players
- Potential Emerging Treatment Option
- High Potential of Market Growth due to Large Target Patient Pool
- Low Cost of Treatment
The dynamics of the Contact Dermatitis market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise efficient treatment options. The launch of emerging therapies is expected during the forecast period. Contact Dermatitis Companies includes Edesa Biotech, Hapten Sciences, and many others. Contact Dermatitis Therapies covered in the report include EB01 Cream, PDC-APB, and many more.
For more details, visit: Contact Dermatitis Market Share